New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement

XLVIvsIXJETF Comparison

ETF 1
XLVI

State Street Health Care Select Sector SPDR Premium Income Fund

This fund is part of
Options Strategies
-0.49%
VS
ETF 2
IXJ

iShares Global Healthcare ETF

This fund is part of
Global Large Cap
-0.85%

State Street Health Care Select Sector SPDR Premium Income Fund (XLVI) belongs to the Options Strategies segment. iShares Global Healthcare ETF (IXJ) is part of the Global Large Cap segment. XLVI's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, IXJ's top sector exposures are Healthcare, Consumer Non-Cyclicals and Consumer Cyclicals. XLVI is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.38% for IXJ. XLVI is up 5.69% year-to-date (YTD) with +$14M in YTD flows. IXJ performs worse with 4.53% YTD performance, and -$505M in YTD flows. Run a side-by-side ETF comparison of XLVI and IXJ below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XLVI vs IXJ performance and flow charts

Performance

-4.0-2.00.02.04.0%Aug 10Aug 17Aug 24Aug 31Sep 8

Cumulative Flows

01,000,0002,000,0003,000,0004,000,000Aug 10Aug 17Aug 24Aug 31Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/10/2026
1M3MYTD1Y3Y5Y
Perf.
XLVI
IXJ
-3.75%-2.73%
+3.97%+6.84%
+5.69%+4.53%
+16.54%+16.47%
n/a+23.97%
n/a+24.37%
Flows
XLVI
IXJ
+$4M-
+$11M+$233M
+$14M-$505M
+$25M-$256M
--$567M
-+$32M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XLVI
IXJ
+11.87%+18.48%
+11.09%+15.84%
n/a+14.22%
n/a+14.55%
Max drawdown
XLVI
IXJ
-4.77%-6.17%
-8.21%-10.83%
n/a-18.04%
n/a-18.04%
Max drawdown duration
XLVI
IXJ
16d16d
115d122d
n/a490d
n/a490d
Trading data

Create an account to view trading data

Join for free
XLVI
IXJ
Last sale
9/11/2026 at 1:30 PM
$25.71
$100.76
Previous close
09/10/2026
$25.73
$100.89
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

XLVI
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
XLVI
IXJ
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
XLVI
IXJ
Last price
$25.71
$100.76
1D performance
-0.07%
-0.13%
AuM$25.47 M$4.14 B
E/R0.35%0.38%
Characteristics
XLVI
IXJ
Management strategyActivePassive
ProviderState Street Investment ManagementiShares
Benchmark-S&P Global 1200 Health Care (Sector) Capped Index
N° of holdings59110
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateJuly 30, 2025November 13, 2001
ESGNoNo
Advertisement
Exposure

Countries

XLVI
USA
97.34%
Other
2.66%
IXJ
USA
69.7%
Switzerland
10.39%
Other
19.91%

Sectors

XLVI
Healthcare
97.32%
Other
2.68%
IXJ
Healthcare
97.09%
Other
2.91%
Advertisement

Diversification

XLVI

Total weight of top 15 holdings out of 15

71.63%
IXJ

Total weight of top 15 holdings out of 15

56.91%

Top 15 holdings

Data as of July 31, 2026
XLVI
Eli Lilly & Co.
15.45%
Johnson & Johnson
10.49%
AbbVie, Inc.
7.54%
UnitedHealth Group, Inc.
6.40%
Merck & Co., Inc.
5.47%
Thermo Fisher Scientific, Inc.
3.63%
Amgen, Inc.
3.53%
Abbott Laboratories
3.13%
Gilead Sciences, Inc.
2.75%
Pfizer Inc.
2.42%
Bristol Myers Squibb Co.
2.27%
CVS Health Corp.
2.27%
Intuitive Surgical, Inc.
2.13%
Danaher Corp.
2.09%
Vertex Pharmaceuticals, Inc.
2.06%
IXJ
Eli Lilly & Co.
10.27%
Johnson & Johnson
6.92%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.35%
Merck & Co., Inc.
4.06%
Roche Holding AG
3.89%
Novartis AG
3.64%
AstraZeneca PLC
3.35%
Thermo Fisher Scientific, Inc.
2.71%
Amgen, Inc.
2.65%
Abbott Laboratories
2.33%
Gilead Sciences, Inc.
2.06%
Novo Nordisk A/S
2.05%
Pfizer Inc.
1.80%
CVS Health Corp.
1.70%
Frequently asked questions about XLVI and IXJ

How have the XLVI and IXJ ETFs performed in 2026?

As of September 10, 2026, XLVI is up 5.69% year-to-date (YTD), while IXJ has returned 4.53%. That puts XLVI better performer ahead so far this year.

Which ETF is attracting more investor money: XLVI or IXJ?

Year-to-date, the XLVI ETF saw +$14M in flows, compared to -$505M for IXJ.

Which ETF is more volatile: XLVI or IXJ?

Over the past year, XLVI had a volatility of 11.09%, while IXJ experienced 15.84%.

Which ETF is bigger: XLVI or IXJ?

As of September 10, 2026, XLVI holds $25.47 M in assets under management (AUM), while IXJ manages $4.14 B.

What sectors do the XLVI and IXJ ETFs invest in?

XLVI leans toward sectors like Healthcare. Meanwhile, IXJ focuses on Healthcare.

What are the top holdings of the XLVI ETF and IXJ ETF?

XLVI top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IXJ holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: XLVI or IXJ?

XLVI holds 59 securities with 71.63% of its assets in the top 15. IXJ has 111 securities and a top 15 weight of 56.91%.

Advertisement
Latest news about XLVI & IXJ
Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder